Patient-Centered Decision Support for Eosinophilic Esophagitis
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT06817213
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- General education control — BEHAVIORALParticipants will complete an online survey before reviewing education material for eosinophilic esophagitis, prior to patient's clinical physician's appointment (this appointment is a standard of care visit). Participants will complete a follow-up survey approximately 3 months after the clinic appointment.
- Decision support tool — BEHAVIORALParticipants will complete an online survey before reviewing tailored educational materials for eosinophilic esophagitis prior to patient's clinical physician's appointment (this appointment is a standard of care visit). The intervention is a tailored, electronic decision support intervention with a patient-facing decision aid (DA) with three components-EoE knowledge/education, values clarifications, and communication. Tailored feedback from the patient will be given to the patient's provider prior to the visit to facilitate shared decision-making in the visit. Participants will complete a follow-up survey approximately 3 months after the clinic appointment.
Study Details
The study team is conducting this project to learn more about how patients with eosinophilic esophagitis (EoE) like to use and receive educational materials about treatment options and treatment decision making. This study will assess the efficacy of a decision support intervention to make decisions about treatment and disease management for patients with EoE and will assess the feasibility and acceptability of the intervention to inform future R01-level studies. The study team hypothesize that deploying the intervention will be feasible, and it will demonstrate high acceptability among EoE patients. Additionally, that patients that use the intervention (vs general education about EoE) will report greater treatment knowledge, increased readiness to choose a therapy, adherence to therapy, and follow-up.
Key Dates
- Start date
- Apr 16, 2025
- Status verified
- Apr 2025
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: General education control groupGeneral educational materials
- Experimental: Decision support tool groupTailored educational materials
Primary Outcome Measure
Feasibility: measured as the proportion of eligible patients that consent to participate in the study [ Time Frame: Recruitment period approximately 18 months ]
Central Contacts
- Kelcie Brophy734-615-0531
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | Joy Chang, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEPHASE3 · Recruiting · Dr. Falk Pharma GmbH · Scottsdale, Arizona
- A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksPHASE2 · Recruiting · Phathom Pharmaceuticals, Inc. · Little Rock, Arkansas
- Molecular Basis of Food AllergyEnrolling By Invitation · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Natural History and Genetics of Food Allergy and Related ConditionsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland